Pcas SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pcas SA with three other
pharmaceutical manufacturers in Europe:
Vectura Group PLC
of the United Kingdom
sales of £168.25 million [US$218.78 million]
of which 100%
was Pharmaceutical Prod),
Deva Holding AS
(688.46 million Turkish Liras [US$194.68 million]
of which 93%
was Pharmaceuticals), and
based in Germany
(164.51 million Euro [US$191.96 million]
of which 84%
was EVT Execute).
During the year ended December of 2016, sales at
Pcas SA were 192.00 million Euro (US$224.04 million).
increase of 7.2%
versus 2015, when the company's sales were 179.09 million Euro.
This was the third consecutive year of growth at Pcas SA.